Trastornos del sueño y enfermedades neurológicas: revisión de la evidencia actual
Salud Medicina e Innovación Journal · 05.08.2026 · 4 (3) · 214-236
DOI: 10.70577/gce53f76 ↗Kurz gefasst
Fachartikel in der Zeitschrift Salud Medicina e Innovación Journal, online erschienen am 05.08.2026. Verfasst von Jorge Abel Anoceto Díaz und 4 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Introduction
Sleep disorders clinically constitute a not uncommon condition in various neurological diseases and may be associated with impaired daytime behavior, more evident symptomatology, worsening quality of life, and poorer clinical evolution. Alterations such as insomnia, excessive daytime sleepiness, rapid eye movement sleep behavior disorder, restless legs syndrome, periodic limb movements, and respiratory disorders present different characteristics depending on the neurological disease and the method used for their assessment.
Objective
To analyze current clinical evidence regarding the relationship between sleep disorders and Parkinson’s disease, Alzheimer’s disease, epilepsy, multiple sclerosis, and stroke in the adult population. Methodology: A systematic review was conducted following the PRISMA 2020 guidelines. The search focused on PubMed/MEDLINE, Scopus, ScienceDirect, and SciELO, including primary studies published between 2021 and 2026 in English and Spanish. Studies involving adults that assessed sleep through polysomnography, respiratory polygraphy, actigraphy, recognized diagnostic criteria, or validated questionnaires were selected. After the identification, screening, and eligibility process, 23 studies were included.
Results
The collected evidence showed a high degree of clinical and methodological concordance. In Parkinson’s disease, poor sleep quality, daytime sleepiness, and rapid eye movement sleep behavior disorder were prominent; in Alzheimer’s disease, insomnia and disruption of the sleep-wake rhythm; in epilepsy, poor sleep quality and its impact on quality of life; in multiple sclerosis, insomnia and restless legs syndrome; and in stroke, respiratory disorders, insomnia, and their association with prognosis. Pharmacological interventions with melatonin and lemborexant, as well as non-pharmacological interventions with exergaming, showed specific benefits, although the therapeutic evidence was limited.
Conclusions
Sleep disorders should be considered in the comprehensive assessment of neurological patients. Longitudinal and multicenter studies, as well as clinical trials with clear diagnostic criteria and outcomes, are required.
Zitieren
APA
Díaz, J. A. A., Torres, J. F. Y., Amaguaya, K. E. P., Macias, P. N. C., & Masache, B. K. L. (2026). Trastornos del sueño y enfermedades neurológicas: revisión de la evidencia actual. Salud Medicina e Innovación Journal, 4(3), 214-236. https://doi.org/10.70577/gce53f76
Vancouver
Díaz JAA, Torres JFY, Amaguaya KEP, Macias PNC, Masache BKL. Trastornos del sueño y enfermedades neurológicas: revisión de la evidencia actual. Salud Medicina e Innovación Journal. 2026;4(3):214-236. doi:10.70577/gce53f76
BibTeX
@article{Daz2026,
author = {Díaz, Jorge Abel Anoceto and Torres, Jimmy Fernando Yaguana and Amaguaya, Katheryn Estefanía Paguay and Macias, Pamela Nicol Castillo and Masache, Bryan Kenneth Lema},
title = {Trastornos del sueño y enfermedades neurológicas: revisión de la evidencia actual},
journal = {Salud Medicina e Innovación Journal},
year = {2026},
volume = {4},
number = {3},
pages = {214--236},
doi = {10.70577/gce53f76}
}
EUVIMED